INLYTA, created in 2001 (United States), from 1125 sister brands and 17478 competing brands. The INLYTA brand is owned by Pfizer Inc, a company listed in New York. INLYTA belongs to the Drug Manufacturers business sector.

INLYTA is a brand of Pfizer Inc (PFE) Share price

Share price and profitability of the share Pfizer Inc (INLYTA)

Buy Pfizer Inc share with

(0% commission and fractional shares)

Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 28.20

Portfolio valuation
Pfizer Inc (INLYTA) over 5 years* USD 19.97

Stock market history Pfizer Inc (INLYTA)

Market prices -> Notoriety

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Pfizer Inc

See more brands of Pfizer Inc

Rival brands
INLYTA

Fusion Pharmaceuticals

POINT BIOPHARMA

OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking

Desirable brands > Pricing Power > 5 major sectors

Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more